2024 Overview of Insulin Glargine Biosimilars
Insulin glargine, a long-acting insulin analog, is a key treatment for diabetes management, ensuring consistent glucose control for up to 24 hours. With the rising global prevalence of diabetes, insulin glargine biosimilars have emerged as an affordable alternative to branded treatments like Sanofi's Lantus, helping to r